Pharm
Nicardipine
search
Nicardipine
, Cardene
See Also
Hypertensive Emergency
Intravenous Antihypertensive
Dihydropyridine Calcium Channel Blocker
Clevidipine
Indications
First-line management of
Hypertensive Emergency
(
Hypertensive Crisis
)
Preferred over
Labetalol
,
Nitroglycerin Drip
, and
Nitroprusside
Use
Esmolol
in
Hypertensive Crisis
if
Heart Rate
control is needed (e.g. AAA or
Aortic Dissection
)
Other Indications (oral, rare chronic use)
Hypertension
Angina
Contraindications
Severe
Aortic Stenosis
Mechanism
Second
Gene
ration
Dihydropyridine Calcium Channel Blocker
Similar activity to
Nifedipine
Pure arterial vasodilation
Decreases
Blood Pressure
Does not effect
Heart Rate
or
Preload
Dosing
Adults with
Hypertensive Emergency
Start: 5 mg/hour
Maximum: 15 mg/hour
Titrate
Increase by 2.5 mg/hour every 5-15 minutes until
Blood Pressure
goal reached or maximum reached (15 mg/hour)
Once goal
Blood Pressure
achieved, titrate down towards 3 mg/hour as long as
Blood Pressure
is controlled
Exercise
caution when titrating dose in renal
Impairment
Transitioning from IV Nicardipine to oral agents
Administer oral
Antihypertensive
1 hour after discontinuing IV infusion
Dosing
Children with
Hypertensive Emergency
Not FDA approved for use in children
Start 0.5 mcg/kg/min IV
Maximum: 3 mcg/kg/min IV
Dosing
Oral for
Hypertension
or
Angina
Start 20 mg orally three times daily
Target 20 to 40 mg orally three times daily
Maximum: 120 mg/day
Transitioning from oral Nicardipine to temporary IV Nicardipine
IV Dose 0.5 mg/hour if using Nicardipine 20 mg orally every 8 hours
IV Dose 1.2 mg/hour if using Nicardipine 30 mg orally every 8 hours
IV Dose 2.2 mg/hour if using Nicardipine 40 mg orally every 8 hours
Adverse Effects
See
Calcium Channel Blocker
Safety
Pregnancy Category C
Unknown safety in
Lactation
Drug Interactions
Nicardipine increases levels of other agents
Cyclosporine
Tacrolimus
Other agents raise Nicardipine levels
Cimetidine
Pharmacokinetics
Well absorbed orally
Short
Half-Life
Metabolism
Reduce dose in significant renal or liver
Impairment
Resources
Nicardipine (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=76fcb7e0-9034-4fcd-be14-ce7e9ccaee2a
References
Orman and Weingart in Majoewsky (2012) EM:RAP 12(2): 6-7
(2022) Presc Lett, Resource #381108, Comparison of
Calcium Channel Blocker
s
(2020) Med Lett Drugs Ther 62(1598): 73-80
Olson (2020) Clinical
Pharmacology
, Medmaster Miami, p. 70-1
Hamilton (2020) Tarascon Pocket Pharmacopoeia
Type your search phrase here